SCHEMBL9302173

SCHEMBL9302173

C=C1CCCN(C(P(=O)(O)O)P(=O)(O)OCC)C1

nearest known ligand 0.37

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FDPS P14324 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9301070 0.83 FDPS (0.37) FDPS
SCHEMBL9302399 0.82 FDPS (0.53) FDPS
SCHEMBL6670360 0.77 FDPS (0.45) FDPS
SCHEMBL5075884 0.77 FDPS (0.45) FDPS
SCHEMBL9301258 0.76 FDPS (0.38) FDPS
SCHEMBL9301453 0.73 FDPS (0.36) FDPS
SCHEMBL9300869 0.71 FDPS (0.38) FDPS
SCHEMBL9303056 0.71 FDPS (0.34) FDPS
SCHEMBL9302643 0.70 FDPS (0.38) FDPS
SCHEMBL9301817 0.70 FDPS (0.38) FDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5350743-A Treatment of osteoporosis KAKEN PHARMACEUTICAL CO., LTD. (JP) 1994-09-27 US disclosed
EP-0498424-A1 Bisphosphonic acid derivatives and bone resorption inhibitors containing them Kaken Pharmaceutical Co., Ltd. (JP) 1992-08-12 EP disclosed